Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN
1997-6933
(print)
ISSN
2500-2139
(online)
Register
Login
Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Clinical Oncohematology
Basic Research and Clinical Practice
ИФ РИНЦ:
0,587
H-INDEX:
16
Home
About the Journal
Aims and Scope
Editorial Board
Peer Review
Publishing Ethics and Malpractice Statement
Indexing and Abstracting
Ownership, management and funding
Open Access Policy and Publication Fee
Articles
Current
Journal pre-proofs
Archive
SUPPLEMENT
Sections
LYMPHOID TUMORS
MYELOID TUMORS
BONE MARROW TRANSPLANTATION
ANEMIAS
AUTOIMMUNE DISEASES
CLINICAL TRIALS
NOVEL CORONAVIRUS INFECTION
NEWS
NEW TECHNOLOGIES
REVIEWS
COMPLICATIONS OF CHEMOTHERAPY
PRACTICAL RECOMMENDATIONS
RARE HEMATOLOGICAL TUMORS AND SYNDROMES
EXPERIMENTAL STUDIES
Submission
Search
Register
Login
Home
/
NEW TECHNOLOGIES
NEW TECHNOLOGIES
Expert Review on the Quality of Responses to the Questions of Multiple Myeloma Patients: A Validation Study of the Medical Artificial Intelligence System “Myelobot”
Aleksander Sergeevich Luchinin, O.E. Ochirova, V.G. Potapenko, V.V. Ryabchikova
81-89
01.01.2026
Fertility Preservation Strategies in Patients with Lymphoproliferative Diseases
A.M. Biryukova, Ya.O. Martirosyan, Valeria Olegovna Shpirko, T.A. Nazarenko, G.S. Tumyan
90-95
01.01.2026
Mutation Profile of Normal and Tumor Cells in a Patient with Multiple Myeloma: A Case Report
A.S. Zhuk, I.I. Kostroma, Elena Igorevna Stepchenkova, D.V. Kachkin, O.B. Belopolskaya, I.V. Zotova, A.D. Garifullin, S.V. Voloshin, S.V. Gritsaev, A.Yu. Aksenova
337-349
09.06.2023
CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022
Sergei Vyacheslavovich Semochkin
1-13
01.01.2023
The Use of Multicolor Flow Cytofluorometry in White Blood Cell Differential: HematoFlow Conception
Svetlana Alekseevna Lugovskaya, F.A. Dyukov, E.V. Naumova, I.Yu. Bugrov, A.I. Kostin
319-325
01.10.2018
oa-antiplagiat
Make a Submission
Make a Submission
Banner ROHS
Indexing Databases
Editor-in-Chief
Gayane Sepugovna Tumyan
ARCHIVE
2026
Issue 1 (2026)
2025
Issue 1 (2025)
Issue 2 (2025)
Issue 3 (2025)
Issue 4 (2025)
2024
Issue 1 (2024)
Issue 2 (2024)
Issue 3 (2024)
Issue 4 (2024)
2023
Issue 1 (2023)
Issue 2 (2023)
Issue 3 (2023)
Issue 4 (2023)
2022
Issue 1 (2022)
Issue 2 (2022)
Issue 3 (2022)
Issue 4 (2022)
2021
Issue 1 (2021)
Issue 2 (2021)
Issue 3 (2021)
Issue 4 (2021)
2020
Issue 1 (2020)
Issue 2 (2020)
Issue 3 (2020)
Issue 4 (2020)
2019
Issue 1 (2019)
Issue 2 (2019)
Issue 3 (2019)
Issue 4 (2019)
2018
Issue 1 (2018)
Issue 2 (2018)
Issue 3 (2018)
Issue 4 (2018)
2017
Issue 1 (2017)
Issue 2 (2017)
Issue 3 (2017)
Issue 4 (2017)
2016
Issue 1 (2016)
Issue 2 (2016)
Issue 3 (2016)
Issue 4 (2016)
2015
Issue 1 (2015)
Issue 2 (2015)
Issue 3 (2015)
Issue 4 (2015)
2014
Issue 1 (2014)
Issue 2 (2014)
Issue 3 (2014)
Issue 4 (2014)
2013
Issue 1 (2013)
Issue 2 (2013)
Issue 3 (2013)
Issue 4 (2013)
ALL ARCHIVE
Keywords
Most Read Articles
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
3518
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
1768
Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
1240
Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
1148
Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
997
Up